<DOC>
	<DOCNO>NCT00259571</DOCNO>
	<brief_summary>The purpose study evaluate retard phosphatidylcholine effective mesalazin prevent acute episode ulcerative colitis . The hypothesis , ulcerative colitis cuased defect barrier function colonic mucus . The background study find phosphatidylcholine content colonic mucus reduce patient ulcerative colitis , healthy inflame part colon .</brief_summary>
	<brief_title>Retarded Phosphatidylcholine Versus Mesalazin Remission Ulcerative Colitis .</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<criteria>diagnosis ulcerative colitis remission ( CAI 3 less ) sign letter content steroid immunosupressants last 6 week least 5 relapse last 3 year last relapse 8 month ago less complete colonoscopy entry pregnancy breast feed steroid immunosuppressant acute episode UC condition complete partial colektomy know intolerance mesalazin severe medical disease colitis</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2005</verification_date>
	<keyword>remission</keyword>
	<keyword>mesalazin</keyword>
	<keyword>non-inferiority study</keyword>
	<keyword>relapse</keyword>
</DOC>